Maiwei Biotech Investor Relations Activity Record List (2024/09/01)
Haitong Securities Co., Ltd.\'s 2024 semi-annual follow-up report on the continuous supervision of Maiwei (Shanghai) Biotechnology Co., Ltd.
Announcement of Resolutions of the 12th Meeting of the 2nd Supervisory Board of Maiwei Biotech
Maiwei Biotech\'s special report on the storage and actual use of funds raised in the 2024 semi-year
Mabwell: Meiwei Biotech voluntarily disclosed the announcement that the Phase III clinical study of 9MW2821 combined with PD-1 monoclonal antibody for first-line treatment of urothelial carcinoma has obtained approval from the CDE.
Announcement of Maiwei Bio's increase in credit and financing amount applications to financial institutions for the 2024 fiscal year.
Announcement of resolutions of the 11th meeting of the second session of the supervisory board of Maiwei Biology.
Maiwei Biological Investor Relations Activity Record (July 02, 2024)
Maiwei Biology Investor Relations Activity Record Form (July 01, 2024)
Record of Investor Relations Activities for Maiwei Biology (June 01, 2024)
Announcement of Maiwei Biology on the convening of the 2023 annual and first quarter of 2024 earnings briefing.
Maiwei Biotech Investor Relations Activity Record List (2024/05/01)
Announcement of Resolutions of the 10th Meeting of the 2nd Supervisory Board of Maiwei Biotech
Haitong Securities Co., Ltd.'s inspection opinion on the termination and re-provision of guarantees for wholly-owned subsidiaries by Maiwei (Shanghai) Biotechnology Co., Ltd. and its wholly-owned subsidiaries
Maiwei Biotech Independent Director Candidate Statement and Commitment (Qin Zhengyu)
Maiwei Biotech Independent Director Nominee Statement and Commitment (Qin Zhengyu)
Review opinions of the Nomination Committee of the 2nd Board of Directors of Maiwei Biotech on candidates for independent directors of the 2nd board of directors
Maiwei Biotech Investor Relations Activity Record List (2024/04/01)
Haitong Securities Co., Ltd.'s inspection opinions on the resignation of the deputy general manager and core technical personnel of Maiwei (Shanghai) Biotechnology Co., Ltd. and the addition of core technical personnel
Maiwei Biotech's announcement on the resignation of the company's deputy general manager and core technical staff and the addition of core technical personnel
No Data
No Data